Professor Lip, MD, is Professor of Cardiovascular Medicine at the University of Birmingham and is based in a busy city centre teaching hospital. He leads a large, multidisciplinary research group (including clinical and laboratory-based components) at the Centre for Cardiovascular Sciences, University of Birmingham, England. He is also Adjunct Professor of Cardiovascular Sciences, Aalborg University, Denmark; and Visiting Professor of Cardiology, Belgrade University, Serbia.
Half of his time is spent as a clinical cardiologist, and he practises the full range of cardiovascular medicine, including outpatient clinics, with large atrial fibrillation and hypertension specialist clinics, and coronary care unit duties. He also undertakes coronary intervention and participates in a 24/7 primary angioplasty rota for ST elevation MIs.
Professor Lip has had a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into international guidelines.
He was selected to the Thomson Reuters Science Watch list of ‘World’s Most Influential Scientific Minds 2014’, a ranking of today’s top 17 scholars who have published the greatest number of hot papers, ranked in the top 0.1% by citations, [issued June 2014; see website: http://sciencewatch.com/sites/sw/files/sw-article/media/worlds-most-influential-scientific-minds-2014.pdf].
In 2014, Professor Lip was ranked by Expertscape as one of the world's leading experts in the understanding and treatment of AF [http://www.prlog.org/12273752-expertscape-ranks-top-doctors-and-hospitals-in-atrial-fibrillation.html].
Professor Lip is a board member of the European Heart Rhythm Association (EHRA) and is Chairman of its scientific documents committee (2013-). He is also on the board of the ESC Acute Cardiac Care Association (ACCA, 2014-).
Professor Lip was on the writing committee for the 8th American College of Chest Physicians (ACCP) Antithrombotic Therapy Guidelines for Atrial Fibrillation, as well as various guidelines and/or position statements from EHRA. He was also on the writing committees of the 2010 ESC Guidelines on Atrial Fibrillation, the 2012 ESC Focused Update Guidelines on Atrial Fibrillation, the 2012 ESC Guidelines on Heart Failure, and the 2014 NICE guidelines on AF. He was Deputy Editor (“content expert”) for the 9th ACCP guidelines on antithrombotic therapy for AF (2012).
Professor Lip has acted as Senior Editor for major international textbooks [eg, Lip GYH, Hall JE (eds) Comprehensive Hypertension. Mosby] and Section Editor on hypertension (eg, Crawford, DiMarco, Paulus Cardiology, now in 3rd edition), as well as contributed to major textbooks [eg, the European Textbook of Cardiovascular Medicine (chapter on atrial fibrillation that serves as the core curriculum for ESC cardiology trainees), and Crawford’s Cardiology textbook chapter on atrial fibrillation, etc. Professor Lip is involved at the senior editorial level for major international journals, including Thrombosis & Haemostasis (Editor-in-Chief, Clinical Studies); Europace (Associate Editor); and Circulation (Guest Editor).